Mode
Text Size
Log in / Sign up

Si-ni-san improves depression-related behaviors in rodent models with large effect sizes in meta-analysisHerbal Formula Shows Promise for Depression in Animals

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that Si-ni-san shows significant antidepressant-like effects in rodent models but remains hypothesis-generating.

This meta-analysis evaluates the effects of Si-ni-san (SNS) on depression-related behavioral outcomes in rodent models. The analysis included 384 animals and reported significant improvements in several behavioral markers. Specifically, sucrose preference (SPT) increased with an SMD of 3.18 (95% CI [2.44, 3.93]). Immobility time in the forced swim test (FST) decreased (SMD = -2.17, 95% CI [-2.86, -1.49]), and immobility time in the tail suspension test (TST) also decreased (SMD = -2.55, 95% CI [-3.31, -1.78]).

Secondary outcomes included increases in monoamine neurotransmitters (MNTs), reductions in hypothalamic-pituitary-adrenal (HPA) axis hormones, and decreases in pro-inflammatory cytokines. These findings suggest a potential pharmacological mechanism for the observed behavioral improvements.

Several limitations impact the certainty of these results, including substantial heterogeneity, risk of bias, and inadequate phytochemical characterization. Because these findings are derived from preclinical rodent models, they are considered hypothesis-generating. Caution is advised when interpreting these results as evidence of antidepressant-like pharmacological effects for human clinical use.

How this fits prior evidence

This meta-analysis provides a new preclinical look at botanical interventions for depression, expanding upon the evidence that Artemisinin and derivatives show antidepressant-like and anti-anxiety effects in preclinical rodent models. While both Si-ni-san and Artemisinin show potential in rodent models, the evidence for both remains of low certainty for human application.

A new meta-analysis pooled data from animal studies to see if a traditional Chinese herbal formula called Si-ni-san could affect depression-like behaviors. The analysis included 384 rodents across multiple experiments. Researchers looked at common behavioral tests, such as sucrose preference and forced swim tests, as well as changes in brain chemicals and stress hormones.

In the behavioral tests, animals given Si-ni-san showed increased sucrose preference, which suggests less anhedonia, and reduced immobility time in forced swim and tail suspension tests, which suggests less despair-like behavior. The analysis also found increases in monoamine neurotransmitters, reductions in HPA axis hormones, and decreases in pro-inflammatory cytokines. However, the safety of Si-ni-san was not reported in these studies.

The authors note several important limitations. There was substantial heterogeneity across the studies, meaning the results varied widely. There was also a risk of bias, and the phytochemical makeup of the herbal formula was not well characterized. Because this is a preclinical meta-analysis in animals, the findings cannot be directly applied to humans. The results are hypothesis-generating and do not prove that Si-ni-san treats depression in people.

What this means for readers: This research is early and does not provide evidence that Si-ni-san is an effective or safe treatment for depression in humans. Anyone considering herbal remedies for depression should talk with their doctor first.

What this means for you:
Animal studies suggest Si-ni-san may help depression-like behaviors, but human evidence is lacking.

Common questions

Is Si-ni-san safe for humans?

The meta-analysis did not report any safety information, such as adverse events or side effects, from the animal studies. Without human trials, the safety of Si-ni-san for people is unknown. Always talk to your doctor before trying any herbal supplement.

What did the study find about Si-ni-san and depression?

In 384 rodents, Si-ni-san increased sucrose preference and reduced immobility time in forced swim and tail suspension tests. It also increased monoamine neurotransmitters and reduced stress hormones and inflammatory cytokines. These are depression-like behaviors and biological markers, not clinical depression in humans.

Can Si-ni-san be used to treat depression in people?

No. This was a preclinical meta-analysis in animals, and the authors say the findings are hypothesis-generating. There is no evidence from human trials that Si-ni-san treats depression. Do not use it as a substitute for proven treatments without consulting your doctor.

What are the limitations of this research?

The analysis found substantial heterogeneity across studies, risk of bias, and inadequate characterization of the herbal formula's phytochemicals. These issues mean the results should be interpreted with caution and cannot be directly applied to humans.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
ContextIn Traditional Chinese Medicine depressive disorders are commonly associated with liver qi stagnation syndrome. Si-ni-san (SNS), a classic formula for soothing the liver and relieving qi stagnation, is widely used for its potential antidepressant-like effects.ObjectiveThis preclinical systematic review and meta-analysis aimed to evaluate the pharmacological effects of SNS on depression-related behavioral outcomes in animal models and to summarize its mechanisms of action.MethodsWe conducted a systematic search of seven databases (including PubMed) for records published up to December 2025. Risk of bias was assessed using SYRCLE’s tool. Meta-analyses were performed using STATA 15.0 and RevMan 5.4. Subgroup and leave-one-out sensitivity analyses were conducted to test the robustness of the findings. Publication bias was assessed using funnel plots and Egger’s test. Trim-and-fill analysis was performed to adjust for potential publication bias. The certainty of evidence was evaluated using a modified GRADE approach for preclinical studies.ResultsA total of 28 studies were included, involving 384 animals and three behavioral tests: sucrose preference test (SPT), forced swim test (FST), and tail suspension test (TST). SNS treatment was associated with increased sucrose preference in the SPT (SMD = 3.18, 95% CI = [2.44, 3.93]), and reduced immobility time in both the FST (SMD = −2.17, 95% CI = [-2.86, −1.49]) and TST (SMD = −2.55, 95% CI = [-3.31, −1.78]). Mechanistically, SNS treatment was associated with increased monoamine neurotransmitters (MNTs), reduced hypothalamic-pituitary-adrenal (HPA) axis hormones, and decreased pro-inflammatory cytokines.ConclusionThese findings suggest that SNS is associated with antidepressant-like pharmacological effects in rodent models, with changes in MNTs, HPA axis hormones, and inflammatory markers. However, due to substantial heterogeneity, risk of bias, and inadequate phytochemical characterization, these results should be considered hypothesis-generating and interpreted with caution.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.